ADVFN
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
TuHURA Biosciences Inc

TuHURA Biosciences Inc (HURA)

2.33
0.00
(0.00%)
0.00
0.00
(0.00%)

TuHURA Biosciences Inc (HURA) Quote

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.33
( - )
Bid
2.30
Ask
2.36
Volume
-
0.00 Day's Range 0.00
1.80 52 Week Range 7.93
Market Cap
Previous Close
2.33
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
246,997
Shares Outstanding
43,680,396
Dividend Yield
-
PE Ratio
-4.49
Earnings Per Share (EPS)
-0.52
Revenue
-
Net Profit
-22.65M

About TuHURA Biosciences Inc

TuHURA Biosciences, Inc. is a Phase III registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company's lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It ... TuHURA Biosciences, Inc. is a Phase III registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company's lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase III registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first line treatment for advanced Merkel cell carcinoma. In addition, the Company is leveraging its Delta receptor technology to develop novel bi-functional antibody drug conjugates (ADCs), targeting myeloid derived suppressor cells to inhibit their immune suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies. Its IFx platform technology utilizes a proprietary plasmid DNA (pDNA) or messenger RNA (mRNA). Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Reno, Nevada, USA
Founded
-
TuHURA Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HURA. The last closing price for TuHURA Biosciences was $2.33. Over the last year, TuHURA Biosciences shares have traded in a share price range of $ 1.80 to $ 7.93.

TuHURA Biosciences currently has 43,680,396 shares outstanding. The market capitalization of TuHURA Biosciences is $101.78 million. TuHURA Biosciences has a price to earnings ratio (PE ratio) of -4.49.

HURA Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.08-3.319502074692.412.552.27491907822.42545726CS
4-0.2-7.905138339922.532.772.15170572.37993426CS
12-1.92-45.17647058824.254.32.12469972.73305082CS
26-2.33-504.665.271.82325023.22824805CS
52-4.22-64.4274809166.557.931.82581864.00314086CS
156-4.22-64.4274809166.557.931.82581864.00314086CS
260-4.22-64.4274809166.557.931.82581864.00314086CS

HURA - Frequently Asked Questions (FAQ)

What is the current TuHURA Biosciences share price?
The current share price of TuHURA Biosciences is $ 2.33
How many TuHURA Biosciences shares are in issue?
TuHURA Biosciences has 43,680,396 shares in issue
What is the market cap of TuHURA Biosciences?
The market capitalisation of TuHURA Biosciences is USD 101.78M
What is the 1 year trading range for TuHURA Biosciences share price?
TuHURA Biosciences has traded in the range of $ 1.80 to $ 7.93 during the past year
What is the PE ratio of TuHURA Biosciences?
The price to earnings ratio of TuHURA Biosciences is -4.49
What is the reporting currency for TuHURA Biosciences?
TuHURA Biosciences reports financial results in USD
What is the latest annual profit for TuHURA Biosciences?
The latest annual profit of TuHURA Biosciences is USD -22.65M
What is the registered address of TuHURA Biosciences?
The registered address for TuHURA Biosciences is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501
What is the TuHURA Biosciences website address?
The website address for TuHURA Biosciences is www.kintara.com
Which industry sector does TuHURA Biosciences operate in?
TuHURA Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AACIUArmada Acquisition Corporation II
$ 10.16
(0.00%)
0
AACIArmada Acquisition Corporation II
$ 10.03
(0.00%)
0
AACGATA Creativity Global
$ 0.8913
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.29
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.12
(0.00%)
0
AACIUArmada Acquisition Corporation II
$ 10.16
(0.00%)
0
AACIArmada Acquisition Corporation II
$ 10.03
(0.00%)
0
AACGATA Creativity Global
$ 0.8913
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.29
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.12
(0.00%)
0
AACIUArmada Acquisition Corporation II
$ 10.16
(0.00%)
0
AACIArmada Acquisition Corporation II
$ 10.03
(0.00%)
0
AACGATA Creativity Global
$ 0.8913
(0.00%)
0
AACBUArtius II Acquisition Inc
$ 10.29
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.12
(0.00%)
0

Discussion

View Full Feed
sylvia07 sylvia07 8 minutes ago
Well said, Johnny, they are working hard to try to convince us, no naked short but telling and talking about themselves.
DBMM
bigstocksnbonds bigstocksnbonds 9 minutes ago
Yay you!!
Chiugray Chiugray 10 minutes ago
Attilathehunt, Why the Shorts are feeling the heat is especially important now. It is because the battle for NWBO is intensifying, and the Shorts are increasingly trapped and want to cover but can't.

Battle of money flows - “Today”:
- NWBO: Focused on R&D with limited funds. C
NWBO
pgsd pgsd 17 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/7/15/ydufcScreenshot_2025-07-15_080345.png
NWBO
thistraderknowsall thistraderknowsall 17 minutes ago
FAI Crypto to $5 surge is inevitable
EVERTHING is AI for the future!!!
littlejohn littlejohn 19 minutes ago
Against market theme of buy fake currency

in U.S.,

bot another small position in a China based

company at large discount to cash value,

Seems like economics 101 was a waste for

schools to ever teach that class,

Ace Trader Ace Trader 19 minutes ago
UP SWING TIME! History repeats !
https://investorshub.advfn.com/uimage/uploads/2025/7/15/ffzpmjkkj.jpg
FNMA
Ace Trader Ace Trader 21 minutes ago
UP SWING TIME !!! History repeats !!
https://investorshub.advfn.com/uimage/uploads/2025/7/15/spgprffff.jpg
FMCC
864 864 23 minutes ago
Congrats All on a very productive day!

Thanks to all for their insight.

Assays next...
Lime Time Lime Time 28 minutes ago
lolol the guy saying he's buying this is bearish on his own investment here at .0003

I'd be ticked off too for losing it all to dilution of the Commons. This is a scam dilution stock. It will go to .000001
AFFU
Shawonsarker84 Shawonsarker84 29 minutes ago
I had to cover for you while you were absent. From June 17,2025, to now, it is almost 4.5B volume traded. Now we have ended up with 800M ask at .0003. I think we might be close. Imo.

"Could very well be. I haven't been watching closely for about a month."
HMBL
Snd101 Snd101 30 minutes ago
I am pretty sure when the share price will reach $20 per share, news reader FFS will manage to find a tread line to tell the world this is going down.
AMRN
OzzieTrader OzzieTrader 30 minutes ago
DTREF
Company focused no BS Investor.
Took a lot of research to make this prediction
Share price will finish green on the OTCQ
DTREF
Schmiggins Schmiggins 32 minutes ago
I read it carefully. It does have two "typos" (a repeated paragraph and a key word missing "week ----".) Someone mentioned it does not tackle the extended trial outcome data - OLE. Data which I remember as being pretty good. So that's a perhaps damning omission. The guy does make a good case for all
AVXL
Ace Trader Ace Trader 36 minutes ago
They have

Fannie Mae, Series R, 7.625% noncumulative preferred shares Equity 837,016 $10,479,440.00

Federal Home Loan Mortgage Corp., Series V, 5.57% noncumulative preferred shares Equity 212,500 $2,428,875.00

Federal Home Loan Mortgage Corp., Ser
FNMA
Mr. C Mr. C 38 minutes ago
Comments from climate activists aren’t going to really do anything. I just ask people to do it so the positives outweigh the negatives for optics, but EPA already made up its mind.

We’ve been through this half a dozen times at least already with Sierra Club and the others on the perm
TGLO
Prestotic Prestotic 38 minutes ago
Dknows, you have been telling this tale tooooo long. I'm starting to think Nebraska is right about you. Are you the water crew?
FUNR
The Danish Dude The Danish Dude 41 minutes ago
It seems he is trying to justify that MHRA is waiting for 10 year survival data which matures Nov 2025

Wow, if that is how you first read that, then I’d like to know your opinion about any given ending to any given whodunnit book 😂

https://media.tenor.com/HxeSO1
NWBO
OzzieTrader OzzieTrader 43 minutes ago
BobRossSon
You are all class my friend, I have also found your posting to be extremely sharp, concise and to the point.
I very much appreciate you my Friend.
I love when the man on the street gets a win, I remember about 20 years ago I worked for an investment bank an the talk o
BobRossSon BobRossSon 46 minutes ago
No matter how this investment plays out—win or lose—I can honestly say I’ve learned a ton.
I’ve always steered clear of pink sheets and OTC markets, so this has been a real eye-opener! I couldn’t pass up this opportunity, though, and dove in headfirst. Reading the daily discussions here and s
canthelpit canthelpit 52 minutes ago
OZZ MAN YOUR THE BEST I & you have humor,,,,I have to run for now ,, I will check back In 2-3 hours when I get up if you would be so kind to put up a closing price ,,,,,,,,,, wait that is a diffrent board,, LOL I will talk with you soon my friend and congrats on the 750,000 b
DTREF

Your Recent History

Delayed Upgrade Clock